Operating Grant : TRANSCAN-3
How to Apply:
The specific objective of this funding opportunity is:
- to improve the efficacy of personalized treatment of cancer patients through the development of new tools and targeted immunotherapy strategies, based on a better understanding of TME functions and of their impact on the disease course.
External Deadline:
Tuesday, June 29, 2021
Funding Source:
External
Funding Level:
Research